Form 8-K - Current report:
SEC Accession No. 0001193125-16-433576
Filing Date
2016-01-20
Accepted
2016-01-20 16:08:41
Documents
3
Period of Report
2016-01-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d125635d8k.htm 8-K 14724
2 EX-99.1 d125635dex991.htm EX-99.1 9111
3 GRAPHIC g125635oncogenexlogo.jpg GRAPHIC 2670
  Complete submission text file 0001193125-16-433576.txt   28907
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 161351106
SIC: 2835 In Vitro & In Vivo Diagnostic Substances